Your browser doesn't support javascript.
loading
Polyoxazoline-Based Nanovaccine Synergizes with Tumor-Associated Macrophage Targeting and Anti-PD-1 Immunotherapy against Solid Tumors.
Matos, Ana I; Peres, Carina; Carreira, Barbara; Moura, Liane I F; Acúrcio, Rita C; Vogel, Theresa; Wegener, Erik; Ribeiro, Filipa; Afonso, Marta B; Santos, Fábio M F; Martínez-Barriocanal, Águeda; Arango, Diego; Viana, Ana S; Góis, Pedro M P; Silva, Liana C; Rodrigues, Cecília M P; Graca, Luis; Jordan, Rainer; Satchi-Fainaro, Ronit; Florindo, Helena F.
Afiliação
  • Matos AI; Grouf of BioNanoSciences - Drug Delivery and Immunoengineering, Research Institute for Medicines (iMed.ULisboa), Department of Pharmacy, Pharmacology and Health Technologies, Faculty of Pharmacy, Universidade de Lisboa, Lisbon, 1649-003, Portugal.
  • Peres C; Faculdade de Medicina, Instituto de Medicina Molecular João Lobo Antunes, Lisbon Academic Medical Center, Universidade de Lisboa, Lisbon, 1649-028, Portugal.
  • Carreira B; Grouf of BioNanoSciences - Drug Delivery and Immunoengineering, Research Institute for Medicines (iMed.ULisboa), Department of Pharmacy, Pharmacology and Health Technologies, Faculty of Pharmacy, Universidade de Lisboa, Lisbon, 1649-003, Portugal.
  • Moura LIF; Faculdade de Medicina, Instituto de Medicina Molecular João Lobo Antunes, Lisbon Academic Medical Center, Universidade de Lisboa, Lisbon, 1649-028, Portugal.
  • Acúrcio RC; Grouf of BioNanoSciences - Drug Delivery and Immunoengineering, Research Institute for Medicines (iMed.ULisboa), Department of Pharmacy, Pharmacology and Health Technologies, Faculty of Pharmacy, Universidade de Lisboa, Lisbon, 1649-003, Portugal.
  • Vogel T; Grouf of BioNanoSciences - Drug Delivery and Immunoengineering, Research Institute for Medicines (iMed.ULisboa), Department of Pharmacy, Pharmacology and Health Technologies, Faculty of Pharmacy, Universidade de Lisboa, Lisbon, 1649-003, Portugal.
  • Wegener E; Grouf of BioNanoSciences - Drug Delivery and Immunoengineering, Research Institute for Medicines (iMed.ULisboa), Department of Pharmacy, Pharmacology and Health Technologies, Faculty of Pharmacy, Universidade de Lisboa, Lisbon, 1649-003, Portugal.
  • Ribeiro F; Department of Chemistry, Faculty of Chemistry and Food Chemistry, School of Science, Technische Universität Dresden, 01062, Dresden, Germany.
  • Afonso MB; Department of Chemistry, Faculty of Chemistry and Food Chemistry, School of Science, Technische Universität Dresden, 01062, Dresden, Germany.
  • Santos FMF; Faculdade de Medicina, Instituto de Medicina Molecular João Lobo Antunes, Lisbon Academic Medical Center, Universidade de Lisboa, Lisbon, 1649-028, Portugal.
  • Martínez-Barriocanal Á; Grouf of BioNanoSciences - Drug Delivery and Immunoengineering, Research Institute for Medicines (iMed.ULisboa), Department of Pharmacy, Pharmacology and Health Technologies, Faculty of Pharmacy, Universidade de Lisboa, Lisbon, 1649-003, Portugal.
  • Arango D; Grouf of BioNanoSciences - Drug Delivery and Immunoengineering, Research Institute for Medicines (iMed.ULisboa), Department of Pharmacy, Pharmacology and Health Technologies, Faculty of Pharmacy, Universidade de Lisboa, Lisbon, 1649-003, Portugal.
  • Viana AS; Group of Biomedical Research in Digestive Tract Tumors, CIBBIM-Nanomedicine, Vall d'Hebron Research Institute (VHIR), Universitat Autònoma de Barcelona (UAB), Barcelona, 08035, Spain.
  • Góis PMP; Group of Molecular Oncology, Lleida Biomedical Research Institute (IRBLleida), Lleida, 25198, Spain.
  • Silva LC; Group of Biomedical Research in Digestive Tract Tumors, CIBBIM-Nanomedicine, Vall d'Hebron Research Institute (VHIR), Universitat Autònoma de Barcelona (UAB), Barcelona, 08035, Spain.
  • Rodrigues CMP; Group of Molecular Oncology, Lleida Biomedical Research Institute (IRBLleida), Lleida, 25198, Spain.
  • Graca L; Centro de Química Estrutural, Departamento de Química e Bioquímica, Institute of Molecular Sciences, Faculty of Sciences, Universidade de Lisboa, Lisbon, 1749-016, Portugal.
  • Jordan R; Grouf of BioNanoSciences - Drug Delivery and Immunoengineering, Research Institute for Medicines (iMed.ULisboa), Department of Pharmacy, Pharmacology and Health Technologies, Faculty of Pharmacy, Universidade de Lisboa, Lisbon, 1649-003, Portugal.
  • Satchi-Fainaro R; Grouf of BioNanoSciences - Drug Delivery and Immunoengineering, Research Institute for Medicines (iMed.ULisboa), Department of Pharmacy, Pharmacology and Health Technologies, Faculty of Pharmacy, Universidade de Lisboa, Lisbon, 1649-003, Portugal.
  • Florindo HF; Grouf of BioNanoSciences - Drug Delivery and Immunoengineering, Research Institute for Medicines (iMed.ULisboa), Department of Pharmacy, Pharmacology and Health Technologies, Faculty of Pharmacy, Universidade de Lisboa, Lisbon, 1649-003, Portugal.
Adv Sci (Weinh) ; 10(25): e2300299, 2023 09.
Article em En | MEDLINE | ID: mdl-37434063
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Macrófagos Associados a Tumor / Melanoma Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Macrófagos Associados a Tumor / Melanoma Idioma: En Ano de publicação: 2023 Tipo de documento: Article